Internal Medicine, Cardiovascular Disease · Lexington, KY
NPI
1386652733
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
Gill Heart Institute 800 Rose St, G100
Lexington, KY, 40536
Phone (859) 323-0295
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,953
156 services
Medicare patients, 2024
86
Average age 69
Drug cost, 2024
$7.9M
2,246 prescriptions
Company payments, 2025
$77.1
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David C Booth was code 99152 (anesthesia), 31 times for 28 patients. In total David C Booth billed 156 services in 22 codes, and Medicare paid $9,953.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99152 Anesthesia | Facility | 31 | 28 | $8.84 | $274 |
| 93010 Electrocardiogram | Facility | 23 | 21 | $6.27 | $144 |
| 93456 Percutaneous Transcatheterization | Facility | 18 | 17 | $215.31 | $3,876 |
| 99214 Office E&M - Established | Facility | 18 | 17 | $74.00 | $1,332 |
By year: 2022 $21K for 263 services; 2023 $14K for 188 services; 2024 $9,953 for 156 services.
Medicare prescription drug claims, 2024
In 2024, the drug David C Booth prescribed most often to Medicare patients was Ambrisentan, with 171 prescriptions and refills. In total David C Booth wrote 2,246 Medicare prescriptions that cost $7.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ambrisentan Generic | 171 | 171 | 17 | $625K |
| Eliquis Apixaban | 153 | 282 | 40 | $151K |
| Tadalafil Generic | 128 | 144 | 19 | $80K |
| Sildenafil Citrate Generic | 106 | 130 | 17 | $98K |
| Adempas Riociguat | 80 | 80 | 13 | $1.1M |
| Bumetanide Generic | 78 | 127 | 27 | $2,587 |
| Orenitram Er Treprostinil Diolamine | 74 | 74 | Under 11 | $991K |
| Losartan Potassium Generic | 74 | 172 | 23 | $423 |
| Winrevair Sotatercept-Csrk | 73 | 73 | Under 11 | $1.4M |
| Opsumit Macitentan | 71 | 71 | Under 11 | $882K |
| Warfarin Sodium Generic | 64 | 132 | 11 | $672 |
| Metoprolol Tartrate Generic | 61 | 151 | 20 | $368 |
| Rosuvastatin Calcium Generic | 61 | 134 | 18 | $453 |
| Ozempic Semaglutide | 60 | 69 | Under 11 | $62K |
| Entresto Sacubitril/Valsartan | 58 | 106 | 15 | $67K |
Brand drugs: 876 claims; generic drugs: 1,370 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David C Booth $77.1 ($77.1 in general payments such as food, travel and fees) from 1 company. The largest payer was Merck Sharp & Dohme LLC with $77.1.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 3 | $77.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.